Compounds for inhibiting NLRP3 and uses thereof

A method of treating a disease, condition, or disorder comprising administering to a human subject in need thereof a compound of Formula (II-h):

• or a pharmaceutically acceptable salt thereof;
• wherein:
• R1 is
• Y is phenyl independently substituted with one, two, or three substituents selected from the group consisting of C1-C6 haloalkyl, halo, and —R4OR5;
• R2a is hydrogen;
• R4 is a bond;
• and
• R5 is hydrogen;
• wherein treating is alleviation of an established symptom of said disease, condition or disorder in said human subject, and
• wherein said disease, condition or disorder is selected from the group consisting of a liver disease, a kidney disease, and a cardiovascular disease.